Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LivOn Labs is a pioneer in the nutraceutical industry, recognized for developing the first liposomal Vitamin C supplement. Founded in 2002, the company utilizes proprietary Liposomal Encapsulation Technology (LET) to enhance the absorption and bioavailability of essential nutrients. Their product line, marketed under the Lypo-Spheric brand, includes formulations for Vitamin C, Glutathione, Alpha Lipoic Acid, and Magnesium. By encapsulating nutrients in phospholipids, LivOn Labs' products bypass traditional digestive barriers that often limit the efficacy of standard oral supplements. The company maintains a commitment to high-quality, non-GMO ingredients and rigorous manufacturing standards. Headquartered in Nevada, LivOn Labs serves a global market of health-conscious consumers and practitioners seeking advanced delivery systems for nutritional support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LivOn Labs.